重组人血小板生成素治疗脓毒症相关性血小板减少症的临床效果分析

doi:10.3969/j.issn.1009-976X.2019.01.020

摘要/Abstract

摘要： ［摘要］目的研究在脓毒症相关性血小板减少症患者的临床治疗中实施重组人血小板生成素治疗的临床疗效。方法经北京大学深圳医院和中山大学孙逸仙纪念医院伦理委员会批准，研究日期于2016年8月至2018年7月，选择两家医院脓毒症伴血小板减少患者共60例展开研究，按治疗方法差异分为两组，重组人血小板生成素（rhTPO）组和乌司他丁组，前者实施rhTPO治疗，15 000 U重组人血小板生成素皮下注射，1次/d，1周为1疗程；后者实施乌司他丁治疗，300 000 U/天的乌司他丁，1周为1疗程。对比分析治疗前后两组患者血小板计数、临床相关指标以及炎性指标改善情况。结果观察组治疗前和治疗后3、5、7天时血小板计数分别为50.54±20.58×109/L；64.20±10.18×109/L；72.61±18.56×109/L；105.60±20.19×109/L血小板计数明显较对照高，P<0.05。两组经治疗后各指标虽有改善但ALT未见有明显变化，观察组Cr、PT、RBC、WBC较对照组改善明显；观察组炎性因子IL?6、IL?8明显较对照组低，P<0.05。结论rhTPO能够提高脓毒症相关性血小板减少症患者的血小板水平且安全，实施rhTPO可能有助改善于脓毒症患者病理过程。

Abstract: ［Abstract］ Objective To investigate the clinical efficacy of recombinant human thrombopoietin （rhTPO） in the clinical treatment of patients with sepsis?associated thrombocytopenia. Methods Approved by the Peking University Shenzhen hospital and SUNYat?senMemorial Hospital， SUN Yat?sen Memorial Hospital University ethics committee， the study was conducted from August 2016 to July 2018. Sixty septic patients with thrombocytopenia from two hospitals were included in the study. Subjects were divided into two groups based on treatments they received： human recombinant platelet hormone （rhTPO） and ulinastatin group. The former received rhTPO treatments， with a dosage of 15000 U human recombinant platelet hormone （shenyang junior pharmaceutical co.， LTD.， S20050048， approved by the drug properties： Biological products， 15 000 units/1 mL/bottle） subcutaneously， 1 time/d， 1 week for a course of treatment. The latter received ulinastatin 300，000U/d （GuangdongTianpu biochemical pharmaceutical co.， LTD.， national drug approval word H19990134） intravenously for a course of 1 week. The platelet count， relevant other clinical and inflammatory indicators were compared and analyzed before and after treatment. Results The platelet count of the observation group before treatment and 3， 5 and 7 days after treatment were 50.54±20.58×109/L；64.20±10.18×109/L；72.61±18.56×109/L；105.60±20.19×109/L respectively， which were significantly higher than that of the control （all P values <0.05）. ALT in two group had not improved， but the levels of Cr， PT， RBC and WBC showed significantly improved，（all P values >0.05）. The indexes of inflammatory factors in the observation group were significantly lower than those in the control group （P<0.05）. Conclusion RhTPO has benefits for the improvement of platelet count among patients with sepsis?related thrombocytopenia and the safety profile is reassuring.

Key words: clinical effect., sepsis, recombinant human thrombopoietin, associated thrombocytopenia, ulinastatin

中图分类号:

R445

龙文汀1，周启棣1，张卫星1，马丽萍2*. 重组人血小板生成素治疗脓毒症相关性血小板减少症的临床效果分析[J]. 岭南现代临床外科, 2019, 19(01): 86-90.

LONG Wenting1， ZHOU Qidi1， ZHANG Weixing， MA Liping2. Recombinant human thrombopoietin for sepsis?associated thrombocytopenia clinical effect analysis[J]. Lingnan Modern Clinics in Surgery, 2019, 19(01): 86-90.

[1]	麦岚, 秦伟强, 许昌琴, 吴娜. 脓毒症患者中糖尿病对病原菌耐药性、疾病严重程度以及临床结局的影响：一项回顾性队列研究[J]. 岭南现代临床外科, 2024, 24(04): 231-237.
[2]	易小玲, 顾杨, 李莉, 余涛. 基于GEO数据库的脓毒症诱发慢加急性肝衰竭关键基因的生物信息学探究[J]. 岭南现代临床外科, 2024, 24(03): 157-161.
[3]	秦伟强, 顾杨, 李莉, 余涛. 基于GEO数据库脓毒症心肌病差异基因的筛选与生物信息分析[J]. 岭南现代临床外科, 2022, 22(03): 285-291.
[4]	顾杨, 刘勋, 区绮云, 张娜, 李涵, 秦伟强, 李莉. 基于深度学习算法的免疫细胞丰度模型预测脓毒症患者的生存预后[J]. 岭南现代临床外科, 2022, 22(02): 154-162.
[5]	黄永锋, 欧荣通, 潘英松. MIS-TLIF术和TLIF术治疗单节段腰椎管狭窄症效果对比[J]. 岭南现代临床外科, 2022, 22(01): 71-74.
[6]	黄锋明, 张炎彬, 王树钦. 倒刺缝线修补胃十二指肠溃疡穿孔的临床观察[J]. 岭南现代临床外科, 2021, 21(04): 425-427.
[7]	黄海明, 陈瑞霞, 袁圆, 叶西就. 右美托咪定作为佐剂用于肝癌手术患者腹横肌平面阻滞的效果评估[J]. 岭南现代临床外科, 2020, 20(05): 614-618.
[8]	刘世乐, 周翠云, 袁友红, 骆成磊, 陈汉文, 唐淑仪, 邢祖民. 乌司他丁对幕上肿瘤切除术患者颈内静脉球部血清SOD和MDA含量的影响[J]. 岭南现代临床外科, 2020, 20(03): 338-340.
[9]	张雯, 张庆元, 鲁洁, 程洁莉. 改良小开窗上颌窦外提升同期种植体植入术的5年临床观察[J]. 岭南现代临床外科, 2020, 20(02): 193-199.
[10]	赵勇, 许圣犬, 徐修磊. 快速康复外科理念在骨盆骨折围术期治疗中的临床效果评价[J]. 岭南现代临床外科, 2020, 20(02): 233-237.
[11]	饶珠峰，赵李业，张进杰，许育源. 增大补片TEP法修补成人脐疝9例报告[J]. 岭南现代临床外科, 2020, 20(01): 59-61.
[12]	洪玉，杜素娟，刘嘉羿，彭书崚，刘婷，王寿平. 乌司他丁对氯胺酮麻醉后幼鼠认知功能及Tau、Aβ蛋白的影响[J]. 岭南现代临床外科, 2018, 18(02): 226-229.
[13]	朱建宏，邹子俊，植耀炜，黄灿霞，李牧，郑咏仪，何志捷. 血栓弹力图在脓毒症患者病情评估中的作用研究[J]. 岭南现代临床外科, 2018, 18(01): 93-96.
[14]	叶华李莉钟贵芳张克林郭瑞莲程慧华何清. SICU严重脓毒症患者血降钙素原和乳酸清除率的临床分析[J]. 岭南现代临床外科, 2015, 15(06): 707-710.
[15]	杨昌宇胡芳铭李汉军肖德茂. 超前镇痛联合多模式镇痛在创伤骨科应用临床疗效及对炎性因子表达影响[J]. 岭南现代临床外科, 2015, 15(06): 710-713.

重组人血小板生成素治疗脓毒症相关性血小板减少症的临床效果分析

Recombinant human thrombopoietin for sepsis?associated thrombocytopenia clinical effect analysis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics